文献速递脊柱外科

单节段退变性脊柱融合术后并发症特异性翻修风险:美国逾39.9万患者队列研究(2010-2023)

Comorbidity-Specific Risk of Revision Following Single-Level Degenerative Spinal Fusion (2010-2023): US Cohort Study Among Over 399K Patients.
PubMed 文献 · Spine (Phila Pa 1976) · 2026-09-28

基于PearlDiver Mariner170理赔数据库(2010-2023)的回顾性队列研究,纳入399,186例接受单节段退变性脊柱融合术的成人患者,随访2年。结果显示贫血(HR 1.33)、骨质疏松(HR 1.31)、物质相关障碍(HR 1.25)和抑郁(HR 1.19)是全因翻修风险最高的术前合并症;骨质疏松、贫血、抑郁和物质相关障碍在假关节、机械失败和邻近节段病(ASD)翻修中均一致相关;高血压(HR 1.20)和2型糖尿病(HR 1.28)仅与机械失败翻修相关,骨关节炎(HR 1.26)仅与ASD翻修相关;无合并症与感染相关翻修显著相关。

要点

  • 骨质疏松、贫血、抑郁和物质相关障碍是全因翻修及非感染性翻修(假关节、机械失败、ASD)的显著预测因素。
  • 高血压和2型糖尿病仅与机械失败翻修风险增加相关,骨关节炎仅与ASD翻修风险增加相关。
  • 无合并症与感染相关翻修显著相关,提示翻修风险因病因不同而异。

核心结论

  • 骨质疏松、贫血、抑郁和物质相关障碍是单节段退变性脊柱融合术后2年内非感染性翻修的显著预测因素。
  • 高血压和2型糖尿病对机械失败翻修风险有较小但显著的影响。

研究设计与样本

  • 回顾性队列研究,使用PearlDiver Mariner170理赔数据库(2010-2023),纳入399,186例接受单节段退变性脊柱融合术的成人患者,随访2年。
  • 采用多变量Cox比例风险模型分析28种术前合并症,调整年龄、性别和所有合并症,Bonferroni校正显著性阈值P≤0.00036。

主要发现

  • 全因翻修风险最高的合并症为贫血(HR 1.33)、骨质疏松(HR 1.31)、物质相关障碍(HR 1.25)和抑郁(HR 1.19)。
  • 2型糖尿病(HR 1.07)和原发性高血压(HR 1.14)对全因翻修风险影响较小但显著。
  • 骨质疏松、贫血、抑郁和物质相关障碍在假关节、机械失败和ASD翻修中均一致相关。
  • 机械失败翻修额外与高血压(HR 1.20)和糖尿病(HR 1.28)相关,而ASD翻修独特地与骨关节炎(HR 1.26)相关。
  • 无合并症与感染相关翻修显著相关。

关键数值与推荐

  • 全因翻修风险:贫血HR 1.33、骨质疏松HR 1.31、物质相关障碍HR 1.25、抑郁HR 1.19、高血压HR 1.14、2型糖尿病HR 1.07(均P<0.001,除非另有说明)。
  • 机械失败翻修风险:高血压HR 1.20、2型糖尿病HR 1.28(P<0.001)。
  • ASD翻修风险:骨关节炎HR 1.26(P<0.001)。
  • Bonferroni校正显著性阈值P≤0.00036。

临床怎么用

  • 支持将合并症纳入术前风险分层,以优化患者选择并减少翻修。
  • 对骨质疏松、贫血、抑郁和物质相关障碍患者应加强围手术期优化。
  • 高血压和糖尿病患者需关注机械失败风险,骨关节炎患者需关注ASD风险。

局限性

  • 基于理赔数据库的回顾性研究,可能存在编码偏倚和未测量混杂因素。
  • 翻修定义依赖CPT/ICD编码,可能低估或高估实际翻修率。
  • 随访仅2年,无法评估长期翻修风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Retrospective cohort. OBJECTIVE: To evaluate the associations of 28 preoperative comorbidities with all-cause and etiology-specific revisions (pseudarthrosis, mechanical failure, adjacent segment disease [ASD], infection) following single-level degenerative spinal fusion. SUMMARY OF BACKGROUND DATA: Revision following spinal fusion for degenerative spinal disease remains frequent and costly. While technical factors are well studied, the extent to which preoperative comorbidities differentially predispose to specific revision etiologies is unclear. MATERIALS AND METHODS: Using the PearlDiver Mariner170 claims database (2010-2023), we identified adults undergoing single-level degenerative spinal fusion and followed them for 2 years for reoperation. All-cause and etiology-specific revisions were defined by CPT/ICD codes. Preoperative comorbidities were analyzed using multivariable cox proportional hazards models adjusted for age, sex, and all comorbidities. Bonferroni correction set significance at P≤0.00036. RESULTS: Among 399,186 patients (mean age 59.7±13.0; 56.7% female; mean CCI 1.4±1.2), anaemia (HR 1.33), osteoporosis (HR 1.31), substance-related disorders (HR 1.25), and depression (HR 1.19) conferred the greatest risk of all-cause revision. Type 2 diabetes (HR 1.07) and essential hypertension (HR 1.14) had smaller but significant effects. Etiology-specific analyses showed that osteoporosis, anaemia, depression, and substance-related disorders were consistently associated with increased risk across pseudarthrosis, mechanical failure, and ASD. Mechanical failure was additionally associated with hypertension (HR 1.20) and diabetes (HR 1.28), which were not significant in the other revision subtypes. In contrast, ASD revisions were uniquely associated with osteoarthritis (HR 1.26). No comorbidity was significantly associated with infection-related revision. All hazard ratios were significant at P<0.001 unless otherwise specified. CONCLUSION: In this national cohort of patients, osteoporosis, anaemia, depression, and substance-related disorders emerged as significant predictors of non-infectious revision within two years. Hypertension and type 2 diabetes conferred more modest risks for mechanical failure. These findings support the integration of comorbidity-informed risk stratification into preoperative planning and highlight the potential optimization to minimize revisions and enhance clinical outcomes.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Kishan A, Khela HS, Manriquez AH, et al. Comorbidity-Specific Risk of Revision Following Single-Level Degenerative Spinal Fusion (2010-2023): US Cohort Study Among Over 399K Patients. Spine (Phila Pa 1976). 2026. PMID: 42804449. doi:10.1097/BRS.0000000000005888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。